Updated:
May 15, 2021 16:28 IST
Under a pre-set lockdown easing roadmap, most businesses in U.K. are set to resume full activity from Monday.
Share Article
AAA
A medical worker prepares an injection with a dose of AstraZeneca coronavirus vaccine, in London. File
| Photo Credit:
Reuters
Under a pre-set lockdown easing roadmap, most businesses in U.K. are set to resume full activity from Monday. The vaccines being administered to protect against COVID-19 are “almost certainly less effective” against preventing the transmission of the B1.617.2 variant first identified in India, a leading UK scientist who advises the country’s vaccination programme said on Saturday.
India’s Covid-19 pandemic is about to get much more complicated.
A crushing second wave of Covid-19, when the country is persistently seeing around 350,000 new infections a day, has
led to a massive increase in cases that require strong medication. Now, the long-term effects of such drugs are leading to cases of a rare fungal infection, which can even prove fatal in some instances.
Mucormycosis, colloquially known as black fungus, is an infection from the mucormycetes group of fungi. It is abundantly found in natural environments, especially in soil. Though rare, this infection has been around for decades, but only impacts those with health conditions and significantly weakened immune systems because of the use of steroids.